🇺🇸 PCRX — Pacira BioSciences, Inc.

Salud Mantener
← Volver

Precio actual

36,40 USD

Máx. histórico

119,27

4270 días

Caída desde máximo

-69,48%

Rango 52 semanas

18,80 – 36,67

Variación hoy

+0,03%

Cierre anterior

36,39

Rango de hoy

36,38 – 36,45

Volumen hoy

2.420.374

Peor caída histórica

-90,19%

25/02/2015 → 09/08/2024

Aún sin recuperar

Volatilidad anualizada ⓘ

50,36%

Información
Nombre completo
Pacira BioSciences, Inc.
Divisa
USD
Mercado
NasdaqGS
Sector
Salud
Industria
Drug Manufacturers - Specialty & Generic
Empleados
825
PER ⓘ
104,00 (puede no estar actualizado)
Dividend yield
0,00% (puede no estar actualizado)
Precio objetivo analistas
33,57 USD (puede no estar actualizado)
Primera cotización
03/02/2011
Precio actualizado
hace 11 horas
Sobre la empresa

Pacira BioSciences, Inc. engages in the development, manufacture, marketing, distribution, and sale of non-opioid pain management and regenerative health solutions to healthcare practitioners in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension for postsurgical pain management; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension indicated for the management of osteoarthritis and knee pain; and iovera system, a non-opioid handheld cryoanalgesia device used to deliver controlled doses of cold temperature to targeted nerves to produce neurolytic block that interrupts the pain-transmitting signals of a peripheral nerve. It also develops PCRX-201, a novel gene therapy vector platform enabling local administration of genetic medicines with the potential to treat large prevalent diseases like osteoarthritis. It has a development and commercialization, and supply agreement with Aratana Therapeutics, Inc. for NOCITA, a bupivacaine liposome injectable suspension product for use in animals. The company was formerly known as Pacira Pharmaceuticals, Inc. and changed its name to Pacira BioSciences, Inc. in April 2019. Pacira BioSciences, Inc. was incorporated in 2006 and is headquartered in Brisbane, California.

Rentabilidad mensual
Evolución
Histórico día a día
Fecha Apertura Máximo Mínimo Cierre Variación Volatilidad día Volumen
19/04/2017 44,15 45,50 44,00 45,00 +2,62% 3,40% 739.100
18/04/2017 45,35 45,35 43,75 43,85 -4,05% 3,53% 801.800
17/04/2017 45,95 46,25 45,30 45,70 -0,44% 2,07% 596.900
13/04/2017 46,05 46,85 44,91 45,90 +0,88% 4,21% 974.100
12/04/2017 46,40 46,65 44,85 45,50 -2,05% 3,88% 743.500
11/04/2017 46,85 47,70 46,05 46,45 -1,17% 3,52% 431.200
10/04/2017 46,40 47,70 45,70 47,00 +1,84% 4,31% 560.600
07/04/2017 46,00 47,00 45,55 46,15 +0,33% 3,15% 887.600
06/04/2017 45,80 46,45 45,25 46,00 +0,66% 2,62% 721.000
05/04/2017 46,25 46,85 45,30 45,70 -0,98% 3,35% 485.300
04/04/2017 46,20 46,75 45,35 46,15 -0,22% 3,03% 527.300
03/04/2017 45,60 46,65 45,50 46,25 +1,43% 2,52% 871.200
31/03/2017 45,85 46,10 45,15 45,60 -0,55% 2,07% 583.500
30/03/2017 47,60 47,65 45,68 45,85 -3,68% 4,14% 666.600
29/03/2017 47,40 48,35 47,25 47,60 +0,42% 2,32% 549.100
28/03/2017 47,50 48,10 46,25 47,40 -0,32% 3,89% 674.500
27/03/2017 46,55 47,85 46,10 47,55 +1,39% 3,76% 575.400
24/03/2017 46,95 47,65 46,35 46,90 -0,11% 2,77% 545.100
23/03/2017 48,00 48,45 46,40 46,95 -2,49% 4,27% 996.900
22/03/2017 46,75 48,25 46,25 48,15 +2,99% 4,28% 901.400
21/03/2017 48,75 49,35 46,10 46,75 -3,91% 6,67% 1.266.900
20/03/2017 47,50 49,23 47,50 48,65 +2,64% 3,64% 590.400
17/03/2017 48,75 48,75 46,65 47,40 -3,17% 4,31% 1.528.600
16/03/2017 48,05 49,55 47,80 48,95 +1,98% 3,64% 933.100
15/03/2017 46,85 48,45 46,30 48,00 +2,78% 4,59% 869.100
14/03/2017 48,15 48,15 46,05 46,70 +0,65% 4,36% 1.021.400
13/03/2017 46,60 46,85 45,50 46,40 -0,54% 2,90% 592.500
10/03/2017 47,45 47,50 45,95 46,65 -0,74% 3,27% 693.600
09/03/2017 48,30 48,65 45,93 47,00 -2,89% 5,63% 1.321.500
08/03/2017 49,40 50,75 48,05 48,40 -0,51% 5,47% 3.329.200